Literature DB >> 2128162

Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine.

R Okeda1, M Shibutani, T Matsuo, T Kuroiwa, R Shimokawa, T Tajima.   

Abstract

Two metabolites of 5-fluorouracil (FU), monofluoroacetic acid (FA) and alpha-fluoro-beta-alanine (FBAL), were continuously administered into the left ventricle of the brain in cats for up to 1 month to investigate the mechanism of neurotoxicity of FU and its derivatives. The cumulative doses of FU and FBAL over a 1-month period were 1.5-45 mg (20 cats) and 0.2-4.8 mg (21 cats), respectively. As controls for each experimental group, acetic acid (AA) and beta-alanine (BAL) were administered. In terms of survival time in relation to the cumulative dose and molecular weight, FBAL was more toxic than FA. Neuropathologically, two types of change, vacuoles and necrosis/softening-like change, were found. The vacuoles were 20-50 microns in diameter, and distributed mainly in the cerebellar nuclei, white matter and the tectum and tegmentum of the brain stem in both experimental groups. Electron microscopically, these vacuoles were due to splitting of the myelin intraperiod line or separation between the axon and the innermost layer of myelin. Necrosis/softening-like change occurred preferentially in the FBAL group and was located symmetrically in the superior and inferior colliculi, oculomotor nuclei and thalamus. Both types of neuropathological change, especially those in the FBAL group, were similar to those found in cats orally administered with FU and its derivatives.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128162     DOI: 10.1007/bf00662639

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Thiamine deficiency encephalopathy in cats.

Authors:  K V JUBB; L Z SAUNDERS; H V COATES
Journal:  J Comp Pathol       Date:  1956-07       Impact factor: 1.311

2.  Monofluoroacetic acid and related compounds.

Authors:  M B CHENOWETH
Journal:  Pharmacol Rev       Date:  1949-12       Impact factor: 25.468

3.  Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs.

Authors:  R Okeda; T Karakama; S Kimura; S Toizumi; T Mitsushima; Y Yokoyama
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 4.  Subacute leucoencephalopathy induced by carmofur, a 5-fluorouracil derivative.

Authors:  S Kuzuhara; N Ohkoshi; K Kanemaru; H Hashimoto; T Nakanishi; Y Toyokura
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

5.  Neuropathology of vigabatrin.

Authors:  D Graham
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

6.  A nine-month chronic toxicity study of tegafur-uracil mixture (UFT) in dogs.

Authors:  K Yamashita; H Sutou; A Maruden; T Takenouchi; K Morita; T Ariyoshi
Journal:  J Toxicol Sci       Date:  1988-05       Impact factor: 2.196

7.  Experimental study on subacute neurotoxicity of methotrexate in cats.

Authors:  M Shibutani; R Okeda
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  The neuropathology of vigabatrin.

Authors:  W H Butler
Journal:  Epilepsia       Date:  1989       Impact factor: 5.864

9.  Subacute neurotoxicity of 5-fluorouracil and its derivative, carmofur, in cats.

Authors:  R Okeda; M Shibutani; T Matsuo; T Kuroiwa
Journal:  Acta Pathol Jpn       Date:  1988-10
  9 in total
  27 in total

1.  Dihydropyrimidine amidohydrolases and dihydroorotases share the same origin and several enzymatic properties.

Authors:  Zoran Gojkovic; Lise Rislund; Birgit Andersen; Michael P B Sandrini; Paul F Cook; Klaus D Schnackerz; Jure Piskur
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

2.  Seizures following subconjunctival 5-FU therapy.

Authors:  René Hoehn; Julia Lamparter; Norbert Pfeiffer; Urs Vossmerbaeumer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

3.  Crystallization and X-ray diffraction analysis of dihydropyrimidinase from Saccharomyces kluyveri.

Authors:  Doreen Dobritzsch; Birgit Andersen; Jure Piskur
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-03-12

4.  Purification, crystallization and X-ray diffraction analysis of dihydropyrimidinase from Dictyostelium discoideum.

Authors:  Bernhard Lohkamp; Birgit Andersen; Jure Piskur; Doreen Dobritzsch
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

5.  Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.

Authors:  H Nakagawa; M Yamada; N Maeda; K Iwatsuki; A Hirayama; K Ikenaka
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Selective death of immature neurons in methylmalonic acidemia of the neonate: a case report.

Authors:  J M Sum; J L Twiss; D S Horoupian
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Carmofur-induced leukoencephalopathy: MRI.

Authors:  S Matsumoto; S Nishizawa; M Murakami; S Noma; A Sano; Y Kuroda
Journal:  Neuroradiology       Date:  1995-11       Impact factor: 2.804

8.  Eukaryotic beta-alanine synthases are functionally related but have a high degree of structural diversity.

Authors:  Z Gojković; M P Sandrini; J Piskur
Journal:  Genetics       Date:  2001-07       Impact factor: 4.562

Review 9.  Pharmacology of fluorinated pyrimidines: eniluracil.

Authors:  S D Baker
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

Review 10.  Diffusion-weighted MRI in neuro-oncology.

Authors:  Joachim M Baehring; Robert K Fulbright
Journal:  CNS Oncol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.